Eli – Investorempires.com

Viking obesity drug to rival Eli Lilly’s: report (NASDAQ:VKTX)

Eli Lilly to buy bowel disease drug developer Morphic for $3.2 billion By Reuters

New Alzheimer’s drug treatment from Eli Lillly wins FDA approval

UK Planning Laws Hinder Investment, Warns Eli Lilly CEO

SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued? (NYSE:LLY)

Eli Azur wins battle for Tamar Petroleum board after NeoGames exit

Denmark’s Novo Nordisk expects 27% sales surge this year but faces price pressure for weight loss drug Wegovy amid Eli Lilly competition

Jefferies sets Eli Lilly price target to $814 By Investing.com

Eli Lilly stock could soar 140% by 2028 as more people use weight-loss drugs, Goldman says

Eli Lilly, Gilead favorites at BofA ahead of Q3 earnings